Cargando…
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program ‘iTHER’
iTHER is a Dutch prospective national precision oncology program aiming to define tumour molecular profiles in children and adolescents with primary very high-risk, relapsed, or refractory paediatric tumours. Between April 2017 and April 2021, 302 samples from 253 patients were included. Comprehensi...
Ejemplares similares
-
P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD CANCER: EXPERIENCE OF THE DUTCH INDIVIDUALIZED THERAPY (ITHER) STUDY’S MOLECULAR TUMOR BOARD
por: Boer, Judith M., et al.
Publicado: (2023) -
W(H)ither the Golgi during Mitosis?
por: Nelson, W. James
Publicado: (2000) -
Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing
por: Hehir-Kwa, Jayne Y., et al.
Publicado: (2022) -
NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target
por: Hiemcke-Jiwa, L. S., et al.
Publicado: (2022) -
Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group
por: Bakhuizen, Jette J., et al.
Publicado: (2021)